Adaptive therapy inhibits chemo-resistance in study
25 February 2016 | By Victoria White
Adaptive therapy is based on evolutionary principals and aims to keep resistant cells in check by maintaining a population of chemo-sensitive cells...
List view / Grid view
News
Gilead announces preclinical results for TLR7 agonist GS-9620
25 February 2016 | By Victoria White
Data from the preclinical study support continued investigation of GS-9620 as part of an HIV eradication strategy…
Pancreatic cancer identified as four separate diseases
24 February 2016 | By Victoria White
A study has revealed that pancreatic cancer is actually four separate diseases, each with different genetic triggers and survival rates, paving the way for more accurate diagnoses and treatments...
Scientists engineer calcium receptors to tune heartbeat strength
24 February 2016 | By Victoria White
Using a modified version of troponin C, researchers showed it can enhance or therapeutically preserve heart function and cardiovascular performance in mice...
Bacteria-killing protein could lead to a new treatment for diabetes
24 February 2016 | By Victoria White
Researchers have discovered that the protein cathelicidin antimicrobial peptide helps the pancreas regenerate and produce insulin...
Avacta to develop Affimer reagents to reduce use of animals in research
Avacta is to develop inhibin Affimer inhibitors. Inhibition of this protein stimulates the production of greater numbers of embryos per mouse...
DNA origami successfully used to kill leukaemia cells
24 February 2016 | By Victoria White
Researchers at The Ohio State University are working on a new way to treat drug-resistant cancer that uses DNA origami packaging...
OncoQR ML’s TYG100 induces strong immune response in pancreatic cancer
23 February 2016 | By Victoria White
In a highly relevant non-human primate model TYG100 was able to induce a strong and clinically relevant immune response...
Plasticell and Pierre Fabre in brown fat enhancement collaboration
23 February 2016 | By Victoria White
Plasticell and Pierre Fabre are to work together to discover plant-based products that enhance the metabolic function of brown adipose tissue...
Desktop Genetics receives grant for site-specific epigenetic CRISPR editing
23 February 2016 | By Victoria White
Given the key role of epigenetics in all tumour types, Desktop Genetics' research has wide potential applications across all histological types of cancer...
Pherecydes Pharma appoints Fanneau de La Horie as CEO
22 February 2016 | By Katie Sadler
Pherecydes Pharma has announced the appointment of Guy-Charles Fanneau de La Horie, MBA as its new Chief Executive Officer.
Researchers use key mechanism to treat autoimmune diseases
19 February 2016 | By Victoria White
The discovery could change the way researchers understand and treat autoimmune diseases such as type 1 diabetes and multiple sclerosis...
Suppressing JNK3 could reduce severity of spinal muscular atrophy
19 February 2016 | By Victoria White
In a study, mice with spinal muscular atrophy saw great improvement when the JNK3 enzyme was genetically inhibited to eliminate its activity...
New nanoparticle has potential to treat ocular cancer
19 February 2016 | By Victoria White
Researchers have developed a new nanoparticle that uses a tumour cell's protective mechanism against itself - short-circuiting tumour cell metabolism and killing tumour cells...
Select Biosciences Second Annual Organ-on-a-Chip World Congress and 3D-Culture, July 7-8, 2016, Boston, USA.
18 February 2016 | By Select Biosciences
Select Biosciences is organizing its 2nd Annual World Congress focusing on Organs-on-Chips—an extremely important and cutting-edge field of important in basic research as well as pharmaceutical discovery and development...
